Combined gemcitabine, ifosfamide and vinorelbine (GIN): activity and safety of a non-platinum-based regimen in advanced non-small-cell lung cancer (NSCLC)

Autor: Baldini, E., Ardizzoni, A., Cafferata, M.A., Del Freo, A., Boni, L., Tibaldi, C., Chella, A., Conte, P.F., Rosso, R.
Zdroj: In European Journal of Cancer 1999 35 Supplement 4:S264-S264
Databáze: ScienceDirect